TL;DR

Flok Health has widened the regulatory clearance on its AI physiotherapy clinic to every musculoskeletal and pelvic health pathway, having previously been limited to back pain and sciatica. The Class IIa certification permits autonomous assessment through to discharge, with no clinician directly in the loop. Hip and knee problems and urinary incontinence now fall inside its scope.

The step most NHS AI stops short of

The distinction worth holding onto is between a pilot and a clearance. Plenty of NHS AI runs on a single ward under supervision; this is a medical device certification covering an entire care pathway, which means the regulator has accepted that a patient can be assessed, treated and signed off without a physiotherapist making the calls. Patients self-refer through a phone app and get video appointments that respond to their answers as the session runs, available at any hour.

Coverage has grown quickly. The service reaches 14 NHS regions, against 11 in February, and Flok says its NHS footprint more than doubled over six months — more than 6.6 million patients can now access the back pain and sciatica offering. The company took a further £9.5m from investors in June, earmarked for exactly this kind of pathway expansion.

The numbers behind the case

Roughly 500,000 people sit on NHS community physiotherapy waiting lists on Flok’s figures, some waiting beyond 18 weeks. Its work with Cambridgeshire Community Services NHS Trust cut the back pain list by more than half and brought waits across all MSK conditions down 44% inside ten weeks. Over 2,500 back pain patients went through the service during that rollout, and 80% of those surveyed rated the experience as good as or better than seeing a physiotherapist face to face.

Chief executive Finn Stevenson framed the argument around supply rather than technology: conventional providers are structurally unable to match demand, so without autonomous capacity the waits and the overstretch simply persist.

Looking forward

That 80% satisfaction figure is the one to watch as scope widens, because back pain is comparatively forgiving territory. Pelvic health and post-surgical knee work carry different risk profiles, and a clearance covering all pathways means the regulator will be judged on the hardest of them, not the easiest. For NHS trusts, the immediate question is procurement: a service already cleared across every community pathway is a materially different purchase from another pilot.